STATUTORY & REGULATORY SPECIFICATIONImplementation Issue 2.0

Terms and Conditions

Corporate Scientific Platform · Dual-Jurisdiction Regulatory Framework (Australia & India) · LAST AUDIT: 26 October 2026

These Terms and Conditions govern access to and use of 36ausbiotech.com (the 'Platform'). 36AUS BIOTECH is a corporate scientific platform dedicated to cosmetic formulation research, ingredient intelligence, and developmental quality transparency. The platform operates without direct consumer e-commerce. Because 36AUS BIOTECH connects an Australian founder perspective and formulation architecture with third-party contract manufacturing in India, these terms incorporate governing statutory standards across both the Commonwealth of Australia and the Republic of India.

MANDATORY STATUTORY STATEMENTS

Compliance Disclosures & Gates

IMPLEMENTATION DOSSIER 2.0 · SECTION XI
SCIENTIFIC & MEDICAL DISCLAIMER

Cosmetic Formulation Rationale Only

"Ingredient information describes the general cosmetic formulation rationale and available source research. Research concerning an individual ingredient should not be interpreted as a clinical finding on a finished product. No content on this site is intended to diagnose, treat, cure or prevent disease. Please consult an appropriately qualified professional regarding medical concerns."

Implementation Dossier 2.0, Section XI · Therapeutic Goods Act 1989 (Cth) / Drugs & Cosmetics Act 1940 (IN)
ORIGIN & MANUFACTURING REPRESENTATION

Australian Perspective · Indian Manufacture

"Australian founder perspective; intended manufacture in India. Exact responsible manufacturer and marketer details will be displayed on the finished product and applicable legal disclosures before sale."

Implementation Dossier 2.0, Section I & XI · ACL Schedule 2 s 18 & Pt 5-3 / Legal Metrology Rules 2011
DEVELOPMENT COLLECTION NOTICE

Formulation Concepts 'In Development'

"Products identified as 'in development' are concepts or development-stage formulations and are not offered for sale. Ingredients, packaging, instructions and availability may change following validation and review."

Implementation Dossier 2.0, Section XI · Quality & Regulatory Pipeline Gate
MEDIA & VISUAL DISCLOSURE

Illustrative Concept Imagery

"Conceptual product and scientific imagery is illustrative. Only images explicitly identified as an actual facility, staff or process are photographs of the named operation."

Implementation Dossier 2.0, Section XI · Media Asset Integrity Standard
AUSTRALIA COMPLIANCE

Australian Consumer Law (ACL)

Compliant with the Competition and Consumer Act 2010 (Cth) Sch 2 s 18 & Pt 5-3. Safe harbour origin representation: French-Inspired. Australian Formulation. Made in India. Strictly no representations of "Australian Made" or "Manufactured in Australia".

INDIA COMPLIANCE

Drugs & Cosmetics / Metrology

Planned compounding, filling, and packaging under licensed third-party Indian contract facilities (Drugs & Cosmetics Act 1940 / Cosmetics Rules 2020) and Legal Metrology (Packaged Commodities) Rules 2011.

BRAND ECOSYSTEM

36AUS & Velari Privé

36AUS BIOTECH is the corporate scientific platform (formulation philosophy, evidence, and quality tracking). Velari Privé is the luxury consumer brand for ritual experience and eventual retail.

CODIFIED ARTICLES

Platform Terms & Operational Provisions

Ten foundational articles defining platform scope, origin representation, cosmetic boundaries, evidence standards, and consumer rights.

ARTICLE 01Dual (Australia & India)

Platform Scope & Brand Ecosystem Distinction

Clear operational separation between 36AUS BIOTECH (corporate science) and Velari Privé (luxury consumer brand).

1.1 Corporate Scientific Platform: 36ausbiotech.com operates strictly as a corporate formulation and cosmetic science platform. It hosts no direct consumer e-commerce checkout, payment gateways, or consumer retail transactions.

1.2 Brand Ecosystem Crossover: 36AUS BIOTECH is the SCIENCE brand focused on formulation philosophy, scientific education, development records, and quality transparency. Velari Privé (velariprive.au) is the LUXURY consumer brand stewarding finished consumer products, beauty narratives, rituals, and eventual retail sales. Both platforms maintain clear bidirectional linking ('The Science Behind the Beauty' on Velari -> 36AUS /science/; 'Discover the Luxury Experience' on 36AUS -> Velari site).

1.3 Non-Commercial Staging: Information on this site is provided for scientific education, regulatory transparency, and technical review.

ARTICLE 02Dual (Australia & India)

Country of Origin & Manufacturing Representation

Strict compliance with safe harbour origin declarations: 'French-Inspired. Australian Formulation. Made in India.'

2.1 Approved Origin Statement: The official and non-negotiable country of origin representation for ANAGENÈSE and formulations developed under 36AUS BIOTECH is: 'French-Inspired. Australian Formulation. Made in India.'

2.2 Absolute Prohibition of Misleading Claims: In accordance with Section 18 and Part 5-3 of the Australian Consumer Law (Schedule 2 of the Competition and Consumer Act 2010 (Cth)) and the Legal Metrology (Packaged Commodities) Rules 2011 (India), 36AUS BIOTECH strictly disclaims and prohibits any representation that finished products are 'Australian Made', 'Made in Australia', or 'Manufactured in Australia'.

2.3 Operating Reality & Manufacturing Vision: 36AUS draws on its founder's long connection with Australia and a commitment to thoughtful cosmetic formulation. Planned commercial manufacturing is in India through qualified third-party contract partners, subject to facility selection, validation, and applicable approvals. 36AUS BIOTECH does not claim an Australian physical laboratory, registered Australian entity, or in-house manufacturing plant absent completed documentation.

ARTICLE 03Dual (Australia & India)

Cosmetic Scope & Non-Medical Charter

Strict classification as topical cosmetic formulations; complete exclusion of therapeutic or hair-regrowth claims.

3.1 Purely Cosmetic Function: The formulations discussed on this platform—including flagship ANAGENÈSE (a leave-on scalp and hair-fibre cosmetic serum) and development concepts ÉCLAT DU CUIR, TRICHÉLLE, and V'ELORA—are strictly cosmetic preparations designed for scalp comfort, moisture balance, and conditioning of the hair fibre.

3.2 Prohibition of Therapeutic Claims: Under the Australian Therapeutic Goods Act 1989 and the Indian Drugs and Cosmetics Act, 1940 (with the Cosmetics Rules, 2020), no statement on this platform constitutes, or may be interpreted as, a therapeutic claim to treat, cure, diagnose, reverse, or prevent androgenetic alopecia, medical hair-loss disorders, DHT inhibition pathology, or any dermatological disease.

3.3 Independent Medical Advice: Any person suffering from sudden, diffuse, or symptomatic scalp disorders or hair shedding should seek evaluation from a licensed dermatologist or medical practitioner.

ARTICLE 04Dual (Australia & India)

Ingredient Intelligence & Evidence Vault Standards

Clear boundary separating supplier raw material research from finished-product clinical efficacy.

4.1 Ingredient Study ≠ Finished-Product Efficacy: Technical citations of in-vitro biochemical assays, supplier ingredient data, peptide binding models, or published botanical studies describe isolated chemical properties and research-stage inputs. These citations do not establish, promise, or imply clinical outcomes on the finished cosmetic formulation.

4.2 Quality & Testing Transparency: All laboratory test statuses published on the platform are categorised strictly as PLANNED, IN PROGRESS, COMPLETED (with specific report reference), or VERIFIED (following formal approval). No default 'passed' status is assigned without documentary verification.

4.3 Formula Integrity: Formula percentages, batch masses, process instructions, and supplier proprietary dossiers are held confidential and protected under trade secret and formulation ownership principles.

ARTICLE 05Dual (Australia & India)

Development Collection & Status Disclosures

Legal status of pipeline formulations (ÉCLAT DU CUIR, TRICHÉLLE, V'ELORA) as non-commercial concepts.

5.1 Concepts In Development: Pipeline products—including ÉCLAT DU CUIR (leave-in scalp & hair mask cream), TRICHÉLLE (anhydrous bioactive lipid serum), and V'ELORA (leave-in detangling spray)—are development-stage concepts and are not offered for sale, commercial order, or pre-order.

5.2 Ongoing Modification: Compositional inputs, application directions, packaging formats, and launch readiness are subject to ongoing stability testing, safety assessor review, and formal regulatory sign-off.

ARTICLE 06Dual (Australia & India)

Media, Visual Assets & Conceptual Representations

Disclosure of concept art, illustrative micro-visuals, and licensed stock assets.

6.1 Illustrative Imagery: Conceptual product packaging, 3D abstract schematics, and fluid dynamics imagery displayed across the site are illustrative. No conceptual rendering shall be interpreted as depicting a physical Australian corporate campus or active commercial facility without verified facility releases.

6.2 Concept Bottle Artwork: ANAGENÈSE artwork and packaging visuals are concepts and references pending final bottle physical inspection and regulatory label verification. Packaging components will be updated upon physical container arrival.

ARTICLE 07Australia (ACL / Cth)

Australian Consumer Law (ACL) Guarantees

Statutory protections and non-excludable consumer rights under Commonwealth law.

7.1 Non-Excludable Guarantees: Nothing in these Terms excludes, restricts, or modifies any consumer guarantee, warranty, right, or remedy conferred by the Australian Consumer Law (Schedule 2 of the Competition and Consumer Act 2010 (Cth)) that cannot be lawfully excluded.

7.2 Information Accuracy: 36AUS BIOTECH takes deliberate care to ensure that technical descriptions and cosmetic characterizations are truthful and substantiated, adhering to Section 18 misleading or deceptive conduct provisions.

ARTICLE 08India (D&C / CPA)

Indian Business Identity & Manufacturing Standards

Indian sole proprietorship identity, third-party licensing, and metrology compliance.

8.1 Indian Business Identity: 36AUS operates under an Indian sole proprietorship / trade identity (GST reference: 36ONVPK7472J1ZR, owner-provided reference subject to certificate verification). Internal operational address is maintained securely and released on commercial packaging in compliance with statutory rules.

8.2 Third-Party Manufacturing Compliance: Physical batch production, filling, and packaging in India are planned through qualified third-party contract manufacturers operating under valid State cosmetics manufacturing licences pursuant to the Drugs and Cosmetics Act, 1940 and Cosmetics Rules, 2020.

8.3 Legal Metrology Standards: Commercial packaging declarations adhere to the Legal Metrology Act, 2009 and the Legal Metrology (Packaged Commodities) Rules, 2011.

ARTICLE 09Dual (Australia & India)

Intellectual Property, Trademarks & Brand Rights

Protection of formulation models, technical schematics, and brand marks.

9.1 Proprietary Materials: All technical schematics, ingredient databases, interactive diagrams, editorial copy, and website software are protected by copyright (© 2026 36AUS BIOTECH / registered entity).

9.2 Trademark Conventions: The symbols ™ and ® are applied strictly in accordance with approved jurisdictional registrations. ANAGENÈSE and 36AUS BIOTECH marks are proprietary assets.

9.3 Commercial Restrictions: Systematic scraping, reverse engineering of formulation tables, or unauthorised re-publication of dossier copy without written consent is strictly prohibited.

ARTICLE 10Dual (Australia & India)

Inquiries, Communications & Dispute Resolution

Routing of inquiries via web contact gateway; structured dual-jurisdiction dispute resolution.

10.1 Structured Communications Gateway: Official correspondence, regulatory verification requests, and technical inquiries must be transmitted via the platform contact form (/contact). Residential addresses and private phone numbers are kept confidential by default.

10.2 Indian Grievance Redressal: In compliance with the Information Technology Act, 2000 and the Consumer Protection (E-Commerce) Rules, 2020, regulatory notices or grievances originating in India are handled through our designated compliance channel.

10.3 Australian Jurisdiction: For Australian users, any dispute arising out of access to platform materials that cannot be resolved through good-faith discussion shall be subject to the courts of New South Wales, Australia.

VERIFIED PRODUCT & REGULATORY QUESTIONS

Frequently Asked Questions

10 VERIFIED CUSTOMER GATES · SECTION X

Official customer answers aligned with formulation specifications, cosmetic classification gates, and country-of-origin standards from Implementation Dossier 2.0.

Q01.What is ANAGENÈSE?

A leave-on scalp and hair-fibre cosmetic serum developed around several complementary formulation objectives, combining moisture-supportive, conditioning, and carefully selected cosmetic active technologies.

GATE: ANAGENÈSE FlagshipREF: Cosmetic Formulation Specification v7.1 · Master Build Dossier 2.0, Section X
Q02.Is this a medicine for hair loss?

No. It is presented as a cosmetic product, not as a treatment for alopecia or a disease. Strictly no therapeutic, medical, or hair-regrowth claims are made.

GATE: Regulatory & Medical BoundariesREF: Therapeutic Goods Act 1989 (Cth) / Drugs & Cosmetics Act 1940 (IN)
Q03.How much should I apply?

The development master specifies about 1 mL once daily; always follow final packaging directions when available.

GATE: Usage & ExperienceREF: Product Development Master v7.1 Directions
Q04.How often?

The development instruction is once daily. Confirm this on the approved retail label.

GATE: Usage & ExperienceREF: Approved Ritual Protocol v7.1
Q05.Should I rinse it off?

The development concept is leave-on; follow the final label.

GATE: Usage & ExperienceREF: Scalp Serum Leave-On Architecture
Q06.Can men and women use it?

The concept is intended for adult scalp care; final safety/marketing scope to be confirmed.

GATE: Usage & ExperienceREF: Adult Scalp Formulation Scope
Q07.When will I see results?

Experiences vary. We do not promise a fixed timetable for hair growth or density; any verified product-study findings will be shown with method and duration.

GATE: Scientific Evidence & TestingREF: Evidence Vault Publication Standard
Q08.Are the ingredients clinically proven?

Some ingredients have published or supplier research, but that does not automatically demonstrate identical results from ANAGENÈSE.

GATE: Scientific Evidence & TestingREF: ASCC & ASCI Formulation Evidence Distinction Guidelines
Q09.Where is it manufactured?

Commercial manufacturing is planned in India with a qualified third-party partner; the specific licensed facility will be disclosed when finalised.

GATE: Manufacturing & OriginREF: Origin Statement: 'French-Inspired. Australian Formulation. Made in India.'
Q10.Can I buy it now?

Availability, market, size and price will be announced once the product has completed relevant approvals and commercial readiness.

GATE: Availability & CommercialREF: Commercial Launch Gate · Master Build Dossier 2.0, Section X
Subject to final regulatory and legal review in Australia (New South Wales) and India (Telangana / Maharashtra) prior to indexation and public production deployment.
SUBMIT REGULATORY INQUIRYREVIEW QUALITY PROTOCOLSPRIVACY POLICY